ERBB2 and triple-negative breast carcinoma: Interestingly, we found that triple-negative breast cancers (in other words, those with negative ER, PR, and HER-2/neu status) were positively correlated to methylation of the RIL/CDH13 panel and negatively correlated to methylation of the HIN-1/RASSFIA panel (Table 4).